Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey.
Organon & Co. develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women’s health in the United States and internationally.
Organon Ceo Kevin Ali (google common licence filter)
Founded: 2020
Employees: 10,000
CEO: Kevin Ali
Website: https://www.organon.com
Organon & Co.
30 Hudson Street
Floor 33
Jersey City
New Jersey7302
United States
Ownership ( over 2.5 % shareholders)
The Vanguard Group, Inc. 12.42%
BlackRock, Inc. 6.36%
Mawer Investment Management Ltd. 5.2%
State Street Global Advisors, Inc. 5.03%
Massachusetts Financial Services Company 3.28%
Lord, Abbett & Co LLC 2.6 %